– Growth hormone (GH) excess after Epiphysis fusion . Majority are due to somatotroph-adenonma (hormone secreting) pituitary tumour).
Clinical features
- 1/3 – show clinical features and Visual field defects
- Headache and sleep apnoea are common
Diagnosis
- GH <0.4 ng/ml (normal adults)
-
- Glucose tolerance test (GTT) – diagnostic (no suppression of GH)
- IGF-1 – raised in acromegaly – plasma value shows 24hr mean
- Vision field – bitemporal hemianopia
- MRI / pituitary function
Treatment
- Untreated – death from heart failure, coronary artery disease, neoplasms
- Need to decrease GH below 0.25ng/ml (considered safe)
- Trans-sphenoidal surgery – better for microadenoma
- Radiotherapy – if surgery isn’t curative + somatostatin analogue (octreotide -negative feedback on growth hormone)
- D2 agonist – bromocriptine [10-60mg], carbergoline [0.5mg]
- GH antag – pegvisomant (injection)